July 5, 2017 — BioStable Science & Engineering Inc. announced the first commercial uses of the HAART 300 Aortic Annuloplasty Device in the U.S. by doctors at the West Virginia University (WVU) Heart and Vascular Institute in Morgantown, W. Va. Lawrence Wei, M.D., Vinay Badhwar, M.D., and J. Scott Rankin, M.D., of the WVU Heart and Vascular Institute were the collaborating surgeons for the procedures. The WVU Heart and Vascular Institute is the first of a select group of leading U.S.

With worldwide cardiovascular deaths at an all-time high, European scientists have developed a new handheld scanner that can read the heart's vital signs like a supermarket barcode reader can scan items at the checkout. This would allow a general practitioner (GP) to diagnose even preclinical patients for the early onset of a disease.

Medtronic recently announced that its Reactive ATP therapy slows the progression of atrial fibrillation (AF) in patients with implanted cardiac devices. A robust, real-world analysis of nearly 8,800 patients was presented as a late breaking clinical trial at EHRA EUROPACE-CARDIOSTIM 2017, June 18-21 in Vienna, Austria.

When diagnosing strokes and heart diseases or looking at tumors, perfusion magnetic resonance imaging (MRI) offers a gentler way to capture the blood flow circulation in the organs. However, the method is far from being implemented to its full potential at many clinics. The Fraunhofer Institute for Medical Image Computing MEVIS in Bremen, Germany organized a workshop entitled “Measurement of Perfusion and Capillary Exchange” from June 21-23 to promote adoption of the method. The event provided information about its applications and the current state of research.

June 30, 2017 — Pulsed cavitation ultrasound can be used to remotely soften human degenerative calcified biosprosthetic valves and significantly improve the valve opening function, according to a novel study published in JACC: Basic to Translational Science. This new noninvasive approach has the potential to improve the outcome of patients with severe bioprosthesis stenosis. 

A novel smartphone application has been developed that can direct first responders to cardiac arrest victims more than three minutes before the emergency services arrive. Each minute increases the chance of survival by 10 percent.

Abiomed Inc. announced the recent publication of a peer-reviewed retrospective study on hemodynamic support with the Impella 2.5 heart pump. The study analyzed patients with acute myocardial infarction complicated by cardiogenic shock (AMICS) undergoing a percutaneous coronary intervention (PCI) on an unprotected left main coronary artery (ULMCA). The study was published in the Journal of Interventional Cardiology.

Edwards Sapien 3 cleared by FDA to use for valve in valve mitral procedures. #DAIC

June 30, 2017 — Here is the list of the most popular pieces of content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of June, based on website analytics of the month’s 118,000 pageviews:  

 

Top Articles:

1. FDA Announces Recall of Maquet Intra-aortic Balloon Pumps
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now